What Is Preimplantation Genetic Testing (PGT)?
Preimplantation genetic testing (PGT) refers to tests used during IVF treatment to evaluate specific genetic or chromosomal characteristics of embryos.
These tests are performed in the laboratory before embryo transfer. Typically, a few cells are removed from an embryo that has reached the blastocyst stage for genetic analysis.
PGT is not a single test. Different types are available depending on the genetic characteristics being examined and the purpose of testing.
The three main categories are PGT-A, PGT-M, and PGT-SR.
Differences Between PGT-A, PGT-M, and PGT-SR
PGT-A: Testing for Chromosomal Aneuploidy
PGT-A (Preimplantation Genetic Testing for Aneuploidy) evaluates differences in the number of chromosomes in embryos.
Human cells normally contain 46 chromosomes. Missing or extra chromosomes in some embryos may affect embryo development and the continuation of pregnancy.
PGT-A may provide information about an embryo’s chromosome number. However, routine PGT-A has not been shown to increase live birth rates in all IVF patients.
Its potential benefits and limitations should be evaluated in light of age, medical history, the number of embryos available, and other individual circumstances.
PGT-M: Testing for Monogenic Disorders
PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) is used to investigate specific inherited conditions associated with a known genetic variant in a family.
For example, when a genetic variant responsible for a particular monogenic disorder has been identified in a family, embryos may be tested for that variant under appropriate conditions.
PGT-M generally requires prior identification of the relevant genetic variant and completion of test-specific preparations.
PGT-M is not a general test that screens for all genetic diseases.
PGT-SR: Testing for Structural Chromosomal Rearrangements
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) may be considered when one parent carries a specific structural chromosomal rearrangement, such as a balanced translocation.
Such rearrangements may result in an unbalanced chromosomal complement in some embryos.
PGT-SR can help evaluate embryos in this context. The scope of testing and interpretation of results depend on the type of rearrangement and the method used.
How Is Preimplantation Genetic Testing Performed?
1. IVF Treatment
Ovarian stimulation, egg retrieval, and fertilization in the laboratory are performed.
2. Embryo Development and Monitoring
Embryos are monitored in the laboratory. Those that reach an appropriate developmental stage are assessed for biopsy.
3. Embryo Biopsy
A few cells are generally removed from the outer cell layer (trophectoderm) of an embryo at the blastocyst stage.
4. Genetic Analysis
The collected cells are analyzed using a method appropriate for the planned type of PGT.
5. Interpretation of Results
Genetic test results are evaluated alongside embryo development, medical history, and other clinical information. Test results alone do not determine pregnancy outcomes.
Biopsied embryos are generally frozen and stored according to the laboratory’s protocol.
How Are PGT Results Interpreted?
The meaning of the results varies depending on the type of test.
Following PGT-A, embryos may be classified as chromosomally normal (euploid), abnormal (aneuploid), or mosaic, depending on the reporting system used. Some results may be inconclusive or uninterpretable.
PGT-M and PGT-SR evaluate different genetic characteristics, so their reporting and interpretation differ from PGT-A.
No PGT method assesses all genetic characteristics of an embryo. The scope and limitations of the results should be explained according to the method used.
What Is Mosaicism?
Mosaicism refers to the presence of cell populations with different chromosomal characteristics within the same embryo.
A mosaic result reported by PGT-A is based on findings from a limited number of biopsied cells. Therefore, it may not accurately represent every cell in the embryo.
Clinical outcomes of mosaic embryos can vary. Such findings should be evaluated individually, considering the laboratory report and current scientific evidence.
What Are the Limitations and Risks of PGT?
- PGT does not guarantee pregnancy or live birth.
- The limited number of cells obtained through biopsy may not always represent the entire embryo.
- Genetic changes outside the scope of the test may not be detected.
- Biopsy and laboratory procedures may carry certain risks for the embryo.
- Some results may be inconclusive or require further assessment.
- Testing may result in no embryos being considered suitable for transfer.
PGT does not eliminate the need for recommended prenatal screening or diagnostic testing during pregnancy. Appropriate prenatal follow-up and genetic counseling remain important.
Frequently Asked Questions
Is PGT Necessary in Every IVF Treatment?
No. The need for PGT depends on the type of test being considered and the patient’s medical and genetic characteristics. Routine PGT-A is not recommended for all patients.
Does PGT Confirm That an Embryo Is Completely Healthy?
No. PGT provides information about specific genetic or chromosomal characteristics. It does not assess all genetic or developmental features of an embryo.
Are PGT-A and PGT-M the Same Test?
No. PGT-A evaluates differences in chromosome number, while PGT-M investigates specific monogenic disorders.
Does an Embryo Reported as Normal After PGT Always Result in Pregnancy?
No. Embryo implantation and the continuation of pregnancy depend on many factors.
Does PGT Eliminate the Need for Genetic Testing During Pregnancy?
No. PGT does not replace prenatal screening or diagnostic testing. Assessments during pregnancy must be planned separately.
Related Information
Medical Disclaimer
The information on this page is intended for general educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. The applicability and suitability of genetic testing are determined through individual medical assessment, genetic counseling, and in accordance with current regulations.